「receptors」の共起表現(2語左で並び替え)

Weblio 辞書 > 英和辞典・和英辞典 > receptorsの意味・解説 > receptorsに関連した共起表現

意味

例文

共起表現

「receptors」の共起表現一覧(2語左で並び替え)

該当件数 : 1154件

1 2 3 4 5 6 次へ＞

The type A GABA	receptors are pentameric chloride channels assembled f
binding and signaling through a TrkC-related	receptors called TrkB.
It can act on	receptors at pre-ganglionic sites in both the sympathe
es can act in numerous ways, often acting as	receptors or ligands (the molecule that activates a re
cell contact, ion conductance, and acting as	receptors.
of flunisolide is to activate glucocorticoid	receptors.
elatively wide gap (>20 µm) to activate 5-HT	receptors located on the dendrites, cell bodies and pr
ere are 11 growth factors that activate ErbB	receptors.
Like capsaicin, capsinoids activate TRPV1	receptors, although they are not hot in the mouth.
both capsaicin and capsinoids activate TRPV1	receptors in the same manner.
promotion sites by ligand activated nuclear	receptors.
Activated I1-imidazoline	receptors trigger the hydrolysis of phosphatidylcholin
gonist is a compound that activates dopamine	receptors in the absence of dopamine.
IP3 enters the cytoplasm and activates IP3	receptors on the smooth endoplasmic reticulum (ER), wh
rmone cortisol that activates glucocorticoid	receptors.
ediated effects but also activates adenosine	receptors, often with opposing (patho-) physiological
ns that serotonin has when it activates 5-HT	receptors.
uronal signaling molecule by activating NMDA	receptors in the brain.
al selectivity by strongly activating 5-HT1A	receptors in the prefrontal cortex while having little
By activating 5-HT2C	receptors, vabicaserin inhibits dopamine release in th
periments using constitutively active BMPR1B	receptors.
ceptor and reverses constitutive activity of	receptors.
ts there are yet more additional cannabinoid	receptors.
Adenosine A3	receptors are G protein-coupled receptors that are inv
anchored cytokines, cell adhesion molecules,	receptors, ligands, and enzymes.
Adopted orphan	receptors in the nuclear receptor group include the fa
localizes with intracellular adrenal steroid	receptors and converts cortisol (an active mineralcort
dy produces antibodies against acetylcholine	receptors, and thus inhibits signal transmission acros
The renal effects allow the	receptors to change the mean pressure in the system in
he rat parotid gland and at alpha adrenergic	receptors.
partial agonist action at Alpha-2 adrenergic	receptors, and TDIQ has been suggested as a possible d
ular domain of the protein which is also the	receptors G protein coupling domain.Therefore editing
tain CCKBR (which respond to gastrin) and M3	receptors (which respond to Ach).
cannabinoid agonist at both the CB1 and CB2	receptors.
rect or indirect activation of CB2 and TRPV1	receptors, and induction of oxidative stress, all cont
as a low affinity for AMPA, kainate and NMDA	receptors.
y over the closely related 5-HT2A and 5-HT2B	receptors.
onsidered a full agonist at both CB1 and CB2	receptors and has Ki values of 0.58nM and 0.68nM respe
mary actions of steroid hormones and nuclear	receptors.
energic, α2-adrenergic, β-adrenergic, and D2	receptors.
nates are innervated by pain and temperature	receptors, via the trigeminal nerve (or, the fifth cra
pe I (I and IB) and two type II (II and IIB)	receptors.
a selective antagonist at dopamine D2 and D3	receptors.
It has high affinity for both CB1 and CB2	receptors, with Ki values of 1.5nM at CB1 and 0.32nM a
ive in synthesizing shape- and ion-selective	receptors, and throughout the 1980s research in the ar
selective agonist for the 5-HT2A and 5-HT2C	receptors, but unlike the corresponding benzocyclobute
r binding affinity for the 5-HT1A and 5-HT2A	receptors, but is less potent in producing drug-approp
eceptor full agonist at both the CB1 and CB2	receptors.
MG-3 is a potent agonist at both CB1 and CB2	receptors with a Ki of 0.32nM at CB1 and 0.52nM at CB2
, the macrophage expresses more CD40 and TNF	receptors on its surface which helps increase the leve
idence for receptor overexpression and spare	receptors suggests that the calculation of the net cha
cardioselectivity and blocks both β1 and β2	receptors.
as fairly high affinity for both CB1 and CB2	receptors, with Ki values of 2.91nM at CB1 and 4.24nM
through a site separate from the CB1 and CB2	receptors, which responds to abnormal cannabidiol, O-1
ved to work by blockading dopamine D1 and D2	receptors in the mesocortical and mesolimbic pathways,
ctive full agonist at the dopamine D1 and D5	receptors.
acts as an agonist at the 5-HT1A and 5-HT1B	receptors and as an antagonist at the 5-HT2C receptor.
signaling pathways, coregulators and nuclear	receptors at a promoter showing local nucleosomal cond
receptor, a weak agonist at both CB1 and CB2	receptors, and an inhibitor of anandamide reuptake.
y over the closely related 5-HT1D and 5-HT1A	receptors.
has some affinity for the 5-HT2A and 5-HT2C	receptors, though it is unlikely that these properties
cannabinoid agonist at both the CB1 and CB2	receptors, but with moderate selectivity for CB2, havi
For example, P2X1 and P2X3	receptors desensitize rapidly (a few hundred milliseco
al class that acts on serotonin and dopamine	receptors.
e I ( I and IB) and two type II (II and IIB)	receptors.
o other areas of the brain, and somatostatin	receptors are expressed at many different sites in the
BN acts as a weak agonist of the CB1 and CB2	receptors, with lower affinity in comparison to THC.
be an antagonist at the GABAA and GABAA-rho	receptors.
or adrenergic, histaminergic, and muscarinic	receptors.
y over the closely related 5-HT2A and 5-HT2C	receptors.
s the neurons by activating AMPA and kainate	receptors, causing an influx of calcium.
cannabinoid agonist at both the CB1 and CB2	receptors.
albicans as virulence factors and toll-like	receptors as relevant mediators of the inflammatory ho
ately equal affinity at both the CB1 and CB2	receptors, having a Ki of 8.0nM at CB1 and 7.0nM at CB
is a potent agonist at both the CB1 and CB2	receptors, with a binding affinity of 0.1nM at CB1 and
Chemokines and their	receptors are important for the migration of various c
cannabinoid agonist at both the CB1 and CB2	receptors.
x selectivity over the related Y1, Y2 and Y4	receptors.
s of beta receptor, designated β1, β2 and β3	receptors.
Several ion channels and neurotransmitters	receptors pre-mRNa are substrates for ADARs.
Chemokines and their	receptors are key regulators of the thymocytes migrati
s in the skin also express NMDA and non-NMDA	receptors.
The D1 and D5	receptors are members of the D1-like family of dopamin
ptor antagonist, antagonizing A1, A2, and A3	receptors almost equally, which explains many of its c
Type I and II	receptors form a stable complex after ligand binding,
has shown that the nicotinic and muscarinic	receptors belong to distinct protein superfamilies.
itionally affinity for the 5-HT2A and 5-HT2C	receptors.
It acts on D1 and α	receptors as a agonist.
the estrogen, androgen and mineralocorticoid	receptors.
ylcholine, GABAA, GABAA-ρ, glycine and 5-HT3	receptors that are composed of five protein subunits w
s found to be an agonist at both CB1 and CB2	receptors.
a ligand for various serotonin and dopamine	receptors.
t has moderate affinity for both CB1 and CB2	receptors, with Ki values of 8.36nM at CB1 and 7.95nM
tive for the β1-adrenergic and β2-adrenergic	receptors.
cterising the active site of the CB1 and CB2	receptors.
rongest actions are at the 5-HT2B and 5-HT2C	receptors and its discriminative cue is mediated prima
interact with muscarinic-2 and muscarinic-4	receptors to inhibit neurally released acetylcholine.
binds to the glucocorticoid and progesterone	receptors and therefore blocks the activity of the end
rons may interact with alpha-2A and alpha-2C	receptors to inhibit neurally released norepinephrine.
utoreceptor similar to the 5-HT1B and 5-HT1D	receptors.
It stimulates dopaminergic and serotonergic	receptors and blocks alpha-adrenoreceptors.
tant for neutrophils acting at BLT1 and BLT2	receptors on the plasma membrane of these cells.
entan), which affect both endothelin A and B	receptors.
Other neurokinin subtypes and neurokinin	receptors that interact with SP have also been reporte
sm is facilitated by D2/D3, nACh, and 5-HT2A	receptors.
and has modest affinity for both CB1 and CB2	receptors, with Ki values of 48.3nM at CB1 and 45.5nM
It acts as an agonist at the 5HT2A and 5HT2C	receptors.
with the exception of the 5-HT2A and 5-HT2C	receptors where it acts as a partial agonist.
cannabinoid agonist at both the CB1 and CB2	receptors.
racts centrally with dopamine and adrenergic	receptors.
Warm and cold	receptors play a part in sensing innocuous environment
mitragynine acts on the mu- and delta-opiate	receptors.
hibitor and agonist at the 5-HT2A and 5-HT2C	receptors.
lectivity over the related 5-HT2B and 5-HT2C	receptors.
ulation, molecular endocrinology and steroid	receptors and transcriptional coactivators.
cannabinoid agonist at both the CB1 and CB2	receptors, with Ki values of 0.46nM at CB1 and 0.69nM
that the differences between GABAС and GABAA	receptors are large enough to justify maintaining the
lso partial agonist of µ-opioid and δ-opioid	receptors, and competitive antagonist of ϰ-opioid rece
high affinity for the dopamine D2, D3 and D4	receptors, as well as serotonin 5-HT1A and 5-HT2A/C re
ist with high affinity to the D2, D3, and D4	receptors, and with moderate affinity for the 5-HT2 re
y over the closely related 5-HT1D and 5-HT1A	receptors.
, and cytoskeletal organization and syndecan	receptors are required for internalization of the HIV-
e, suggesting a role for the 5-HT6 and 5-HT7	receptors in regulation of the hearing system.
the antigen receptor (TCR) and costimulatory	receptors (CD28 and ICOS) are thought to be main recep
The D1 and D5	receptors have a high degree of structural homology an
selective for Y4 over the related Y1 and Y5	receptors, as the first non-peptide Y4 antagonist deve
Unlike the H1 and H2	receptors which have primarily peripheral actions, but
lectivity over the related 5-HT2A and 5-HT2C	receptors.
HT2C), 5-HT6, 5-HT7, α1-adrenergic, and NMDA	receptors, and as agonists at the sigma receptors (σ1
activated so that the actions of the δ and κ	receptors can be studied separately, in contrast to be
d efficacious agonist at the M1 and δ-opioid	receptors, unlike clozapine as well.
s, including stimulation of alpha and beta-1	receptors and inhibition of noradrenaline and tyramine
oximately equal affinity for the CB1 and CB2	receptors, with a Ki of 6.6nM at CB1 and 6.9nM at CB2.
, the ATP sensitivity of P2X1, P2X3 and P2X4	receptors is attenuated when the extracellular pH<7, w
hannels including the GABAA, NMDA, and sigma	receptors.
y over the closely related 5-HT2A and 5-HT2C	receptors and other receptor targets.
t as non-selective antagonists at A1 and A2A	receptors in both heart and brain and so have the oppo
ptor alpha, a subunit shared by IL13 and IL4	receptors.
antagonist at various serotonin and dopamine	receptors.
0 mg/day due to its ability to antagonise H3	receptors and thus increase the release of serotonin a
uscle rather than by antagonizing muscarinic	receptors.
M, and no significant affinity for any other	receptors tested.
eptor" family of apoptosis-inducing cellular	receptors.
of its potency, because the appropriate CB1	receptors are not located in brain areas reponsible fo
Several of these are Integrin	receptors.
There are numerous	receptors that now known to use intracellular kinases
In biochemistry, there are decoy	receptors, decoy substrates and decoy RNA.
d to a discovery that there are cell-surface	receptors that are stimulated by hormones and neurotra
n potential formation, there are not as many	receptors for GABA to bind to - meaning that sympathet
ts like osteoprotegerin as both act as decoy	receptors for osteoblastic RANKL.
stranded DNA) molecules which act as surface	receptors.
of deep burn there will be no pain as these	receptors will be burned off.
As IP3	receptors have sparse or little distribution throughou
clear receptor family such as glucocorticoid	receptors.
antiadhesive agents, and second as adhesion	receptors.
eins that appear to function as cell-surface	receptors for Wnts.
PKC family members also serve as major	receptors for phorbol esters, a class of tumor promote
CD16 has been identified as Fc	receptors FcγRIIIa and FcγRIIIb.
ked to the D3 activity of pramipexole, as D3	receptors are heavily expressed in brain regions invol
egral proteins that function as cell-surface	receptors for Wnts called serpentine receptors.
Hence NCOA2 assists nuclear	receptors in the upregulation of DNA expression.
Muscles and associated sensory	receptors are innvervated by type I and II sensory fib
rimary tumor mass, and if HA associates with	receptors such as CD44, the activation of Rho GTPases
ed to THC, which is a partial agonist at CB1	receptors, JWH-018 (and many of its analogues) are ful
lecule to continuously bind and unbind at β2	receptors in the smooth muscle in the lungs.
acts as a nonselective full agonist at GABAA	receptors.
selective, mixed agonist-antagonist at GABAA	receptors, which acts as a partial agonist at the α2 a
culline, ROD-188 acts as an agonist at GABAA	receptors, being a positive allosteric modulator actin
acts as a partial agonist at benzodiazepine	receptors.
ative drug which acts as an agonist at GABAA	receptors, specifically acting as a positive allosteri
a subtype-selective partial agonist at GABAA	receptors, and was developed by Pfizer as a potential
as, , had a direct action at pharmacological	receptors and thereby acting as a neurotransmitter was
shown to possess some activity at serotonin	receptors.
n the mammalian brain where it acts at GABAA	receptors, which are ligand-gated chloride channels.
the mammalian brain where it acts at GABA-A	receptors, which are ligand-gated chloride channels.
Meclozine is an antagonist at H1	receptors.
cts as a partial agonist/antagonist at these	receptors.
t acts as an inverse agonist at melanocortin	receptors, specifically, MC1.
ts also commonly have action at α-adrenergic	receptors and/or 5-HT receptors.
in the mammalian brain where it acts at GABA	receptors, which are ligand-gated chloride channels.
e action of aldosterone at mineralocorticoid	receptors.
te, some of which also act at benzodiazepine	receptors.
the estrogenic potency of coumestrol at both	receptors is much less than that of 17β-estradiol.
a subtype-selective partial agonist at GABAA	receptors, with highest affinity for the α3 subtype, b
subtype, and little or no affinity at other	receptors.
4 is a nonselective partial agonist at GABAA	receptors.
nvulsant shown to act as an agonist at GABAA	receptors.
the mammalian brain where it acts at GABA-A	receptors, which are ligand-gated chloride channels.
The weak agonist activity of pergolide at D1	receptors somewhat alters its clinical and side effect
It is a partial agonist at CB1	receptors, with a Ki of 87nM, making it roughly half t
esearch which acts as an antagonist at GABAB	receptors.
t but non-selective partial agonist at GABAA	receptors, although with little efficacy at the α1 sub
Semorphone is a partial agonist at μ-opioid	receptors.
ion of 2-heptanone as a pheromone at odorant	receptors in mice has been investigated.
It is a partial agonist acting at GABAA	receptors in the brain.
211, is a mixed agonist-antagonist at opioid	receptors with a similar pharmacological profile to pe
phic factor (BDNF), glutamate acting at NMDA	receptors, dopamine through activation of the D1 recep
subtype, with little or no affinity at other	receptors.

1 2 3 4 5 6 次へ＞

共起表現

「receptors」の共起表現(2語左で並び替え) - Weblio英語共起表現検索

「receptors」の共起表現一覧(2語左で並び替え)